AVEO Pharmaceuticals, Inc. (AVEO)

[Biotech Pharmer]

Tivo is superior to Sora in every single way except O/S, which is maturing to be about the same. FDA approval coming, as European effectiveness of the drug that's already on the market is showing its superiority. Every oncologic publication is stating things like this: https://www.oncozine.com/tivozanib-improved-pfs-and-was-better-tolerated-compared-with-sorafenib-in-patients-with-mrcc/

But I'm sure 2 internet board trolls know better.